Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Siena

Showing results (1-10 of 276) with videos related to

Pageof 28
Sort By:
Tumori|February 25, 2003
[4th National Conference of Medical Oncology. Evolution of the technology and clinical objectives of antitumor therapy]Salvatore Siena, Francesco Ferraù
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancerAlberto Bardelli, Salvatore Siena
ESMO Open|September 10, 2020
Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic <i>NTRK</i> targeted cancer therapiesElena Ardini, Salvatore Siena
Handbook of Experimental Pharmacology|April 7, 2017
Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Salvatore Siena
JAMA Oncology|October 20, 2017
Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
JAMA Oncology|August 16, 2019
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
ESMO Open|November 16, 2016
<i>NTRK</i> gene fusions as novel targets of cancer therapy across multiple tumour typesAlessio Amatu, Andrea Sartore-Bianchi, Salvatore Siena
Cancer Cell|August 29, 2020
Breaking Barriers in HER2+ CancersSalvatore Siena, Silvia Marsoni, Andrea Sartore-Bianchi
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 17, 2016
Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trialsReija Koukakis, Francesca Gatta, Guy Hechmati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Iron supplement in cancer patients receiving erythropoietinPaolo Pedrazzoli, Cinzia Tullio, Giulio Cerea, et al.
Pageof 28

Showing results (1-10 of 276) with videos related to

Sort By:
Pageof 28
Tumori|February 25, 2003
[4th National Conference of Medical Oncology. Evolution of the technology and clinical objectives of antitumor therapy]Salvatore Siena, Francesco Ferraù
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancerAlberto Bardelli, Salvatore Siena
ESMO Open|September 10, 2020
Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic <i>NTRK</i> targeted cancer therapiesElena Ardini, Salvatore Siena
Handbook of Experimental Pharmacology|April 7, 2017
Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Salvatore Siena
JAMA Oncology|October 20, 2017
Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
JAMA Oncology|August 16, 2019
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
ESMO Open|November 16, 2016
<i>NTRK</i> gene fusions as novel targets of cancer therapy across multiple tumour typesAlessio Amatu, Andrea Sartore-Bianchi, Salvatore Siena
Cancer Cell|August 29, 2020
Breaking Barriers in HER2+ CancersSalvatore Siena, Silvia Marsoni, Andrea Sartore-Bianchi
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 17, 2016
Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trialsReija Koukakis, Francesca Gatta, Guy Hechmati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Iron supplement in cancer patients receiving erythropoietinPaolo Pedrazzoli, Cinzia Tullio, Giulio Cerea, et al.
Pageof 28